Using chronic MOG35–55-induced experimental autoimmune encephalomyelitis (EAE), a widely used model of MS, we investigated here the curative potential of peripheral orexin A administration in the clinical development of ongoing disease. The gene discussed is HCRT; the disease is experimental autoimmune encephalomyelitis.